{
    "Title": "An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans",
    "URL": "https://doi.org/10.1371/journal.pntd.0008517",
    "Published": "August 18, 2020",
    "Subject_Areas": [
        "Schistosoma mansoni",
        "Schistosoma haematobium",
        "Schistosoma",
        "Schistosoma japonicum",
        "Crystal structure",
        "Drug research and development",
        "Enantiomers",
        "Drug therapy"
    ],
    "Authors": {
        "Meghan A. Guzman": [
            "Departments of Biochemistry and Structural Biology, the University of Texas Health Science Center, San Antonio, Texas, United States of America",
            "Pathology and Laboratory Medicine, the University of Texas Health Science Center, San Antonio, Texas, United States of America"
        ],
        "Anastasia R. Rugel": [
            "Departments of Biochemistry and Structural Biology, the University of Texas Health Science Center, San Antonio, Texas, United States of America",
            "Pathology and Laboratory Medicine, the University of Texas Health Science Center, San Antonio, Texas, United States of America"
        ],
        "Reid S. Tarpley": [
            "Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio, San Antonio, Texas, United States of America"
        ],
        "Sevan N. Alwan": [
            "Departments of Biochemistry and Structural Biology, the University of Texas Health Science Center, San Antonio, Texas, United States of America"
        ],
        "Fr\u00e9d\u00e9ric D. Chevalier": [
            "Program in Host-Pathogen Interactions, Texas Biomedical Research Institute, San Antonio, Texas, United States of America"
        ],
        "Dmytro P. Kovalskyy": [
            "Departments of Biochemistry and Structural Biology, the University of Texas Health Science Center, San Antonio, Texas, United States of America"
        ],
        "Xiaohang Cao": [
            "Departments of Biochemistry and Structural Biology, the University of Texas Health Science Center, San Antonio, Texas, United States of America"
        ],
        "Stephen P. Holloway": [
            "Departments of Biochemistry and Structural Biology, the University of Texas Health Science Center, San Antonio, Texas, United States of America"
        ],
        "Timothy J. C. Anderson": [
            "Program in Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, Texas, United States of America"
        ],
        "Alexander B. Taylor": [
            "Departments of Biochemistry and Structural Biology, the University of Texas Health Science Center, San Antonio, Texas, United States of America",
            "X-ray Crystallography Core Laboratory, Institutional Research Cores, University of Texas Health Science Center, San Antonio, Texas, United States of America"
        ],
        "Stanton F. McHardy": [
            "Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio, San Antonio, Texas, United States of America"
        ],
        "Philip T. LoVerde": [
            "Departments of Biochemistry and Structural Biology, the University of Texas Health Science Center, San Antonio, Texas, United States of America",
            "Pathology and Laboratory Medicine, the University of Texas Health Science Center, San Antonio, Texas, United States of America"
        ]
    }
}